Stem Cell Research Advancement Act of 2010

H.R. 4808/S. 3766 Stem Cell Research Advancement Act

Client expense: $100,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE

H.R. 4808/S. 3766 Stem Cell Research Advancement Act

Client expense: $100,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Nominations to the Patient Centered Outcomes Research Institute Methodologies Commitee; allowing federal funds for human embryonic stem cell research: Stem Cell Research Advancement Act (HR 4808/S 3766).

Client expense: $90,000 · Firm income: Not reported

Government targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Natl Science Foundation (NSF), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Vice President of the U.S.

H.R. 5116 the America COMPETES Act provisions concerning the authorization of appropriations and programs for NSF, DOE Office of Science (including ARPA-e and the Energy Innovation Hubs) and NIST. H.R. 4808/S. 3766 Stem Cell Research Enhancement Act provisions to authorize and regulate the use of human embryonic stem cells in federally funded research. H.R. 2965/S. 1233 SBIR/STTR Reauthorization Act provisions concerning the setaside from federal research budgets to fund the SBIR/STTR programs.

Client expense: $160,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3668/ S. 3058, Reauthorization of the Special Statutory Funding Program for Type 1 Diabetes Research and The Special Diabetes Program for Indians H.R. 4808, Stem Cell Research Advancement Act of 2009 S.3766, Stem Cell Research Advancement Act of 2010 H.R. 4994, Medicare and Medicaid Extenders Act of 2010 H.R. 4853, Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010

Client expense: $100,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbied on injunction to halt Embryonic Stem Cell Research H.R. 4808/S. 3766--Stem Cell Research Advancement Act (Lobbied in support of bill)

Client expense: $207,618 · Firm income: Not reported

Government targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE

HR 5116, HR 5325, S 3605, Reauthorization of America COMPETES Act, Issues pertaining to NSF. S 3766, Stem Cell Research Advancement Act of 2010, All provisions.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

H.R. 3664 - Healthcare Innovation Zone Program Act of 2009 P.L. 111-148, H.R. 3590 - Patient Protection and Affordable Care Act CMS Proposed Inpatient Coding Adjustment Health Information Technology, Meaningful Use Criteria H.R. 4808, S. 3766 - The Stem Cell Research Advancement Act Medicare Wage Index Federal Medical Assistance Percentage Extension Graduate Medical Education

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1704/S. 682, The Mental Health on Campus Improvement Act, entire bill. HR 872, Stem Cell Research Improvement Act of 2009, entire bill. HR 873/S. 487, Stem Cell Research Enhancement Act of 2009, entire bill. S. 973/HR 2251, Resident Physician Shortage Reduction Act, entire bill. HR 4808, Stem Cell Research Advancement Act of 2009. S. 3766, Stem Cell Research Advancement Act of 2009.

Client expense: $140,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Embryonic Stem Cell Research Issues Sickle Cell Disease Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Comparative Effectiveness Research Stem Cell Research Advancement Act (H.R. 4808 / S. 3766) Stem Cell Therapeutic and Research Reauthorization Act of 2010 (S. 3751 / H.R. 6081) Use of Cesium-137 Chloride (CsCl) sources in biomedical research

Client expense: $30,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE

H.R. 5116 Reauthorization of America COMPETES Act authorization of Science research agencies and programs H.R. 5325 Reauthorization of America COMPETES Act authorization of Science research agencies and programs S. 3605 Reauthorization of America COMPETES Act authorization of Science research agencies and programs H.R. 5781 NASA Reauthorization NASA Space Science and Earth Science programs S. 3729 NASA Reauthorization NASA Space Science and Earth Science programs S 4053 Small Business Innovation Research/Small Business Technology Transfer (SBIR/STTR) reauthorization - provisions changing research set-asides for small business. H.R. 4808 Stem Cell Research Advancement Act expansion of federal funding for human embryonic stem cell research S. 3766 Stem Cell Research Advancement Act expansion of federal funding for human embryonic stem cell research

Client expense: $140,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Contacts to oppose H.R. 4808, a bill to encourage federal funding of research that requires the killing of human embryos, including the creation of human embryos by cloning for the specific purpose of using them in research that will kill them ("clone and kill"), and and revised or successor legislation with similar purposes, including S. 3766. Contacts in support of H.R. 1050, the Stupak-Wamp Human Cloning Prohibition Act, and H.R. 877, the Forbes-Lipinski Patients First Act. Contacts in support of extension (continued) into FY 2010-2011 of the Dickey-Wicker provision prohibiting the use of funding within the DHHS appropriations bill or pertinent temporary funding measures for "research in which" human embryos are harmed or placed at risk.

Client expense: $119,232 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 4872 - Reconciliation Act of 2010 - in support. In support of HR 4808/S 3766 - Stem Cell Research Advancement Act Support for FMAP extension. In support of HR 4944 - SGR/GME Extenders Bill Health and Human Services Appropriations - Increased funding for the Department of Health and Human Services including National Institutes of Health research programs and Title VII and Title VIII (Health Professions) funding; Poison Control Centers and programs for teaching and research at academic medical centers; in support of HRSA project funding.

Client expense: $120,000 · Firm income: Not reported

Government targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE

HR 4872 - Reconciliation Act of 2010 - in support. In support of HR 4808/S 3766 - Stem Cell Research Advancement Act Support for FMAP extension. In support of HR 4944 - SGR/GME Extenders Bill Health and Human Services Appropriations - Increased funding for the Department of Health and Human Services including National Institutes of Health research programs and Title VII and Title VIII (Health Professions) funding; Poison Control Centers and programs for teaching and research at academic medical centers; in support of HRSA project funding.

Client expense: $120,000 · Firm income: Not reported

Government targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE

HR 4872 - Reconciliation Act of 2010 - in support. In support of HR 4808/S 3766 - Stem Cell Research Advancement Act Support for FMAP extension. In support of HR 4944 - SGR/GME Extenders Bill Health and Human Services Appropriations - Increased funding for the Department of Health and Human Services including National Institutes of Health research programs and Title VII and Title VIII (Health Professions) funding; Poison Control Centers and programs for teaching and research at academic medical centers; in support of HRSA project funding.

Client expense: $110,000 · Firm income: Not reported

Government targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE

H.R. 4808/S.3766, the Stem Cell Research Advancement Act. Support H.R. 4808, no position on S. 3766. Legislation codifies the Obama Administrations Executive Order and National Institutes of Health guidelines regarding federal funding of human embryonic stem cell research. (Lobbyists used: Lisa Cox)

Client expense: $140,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE

S. 3766, H.R. 4808, Stem Cell Research Advancement Act. Federal funding of human embryonic stem cell research.

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

General advocacy for NIH research; improved conflict of interest policies. S. 3766/H.R. 4808 - Stem Cell Research Advancement Act of 2010 -- A bill to amend the Public Health Service Act to provide for human stem cell research, including human embryonic stem cell research, and for other purposes. Advocacy in support of clear, productive federal stem cell research guidelines.

Client expense: $40,000 · Firm income: Not reported

Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE

H.R. 4808/S. 3766, Stem Cell Research Advancement Act. Issue: Support authorization of federal funding for human embryonic stem cell research.

Client expense: $220,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Natl Science Foundation (NSF), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, Veterans Affairs, Dept of (VA), White House Office

Federal Medical Assistance Percentage Extension H.R. 3664 - Healthcare Innovation Zone Program Act of 2009 P.L. 111-148, H.R. 3590 - Patient Protection and Affordable Care Act CMS Proposed Inpatient Coding Adjustment Health Information Technology, Meaningful Use Criteria H.R. 4808, S. 3766 - The Stem Cell Research Advancement Act

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Contacts to oppose H.R. 4808, a bill to encourage federal funding of research that requires the killing of human embryos, including the creation of human embryos by cloning for the specific purpose of using them in research that will kill them ("clone and kill"), and and revised or successor legislation with similar purposes, including S. 3766. Contacts in support of H.R. 1050, the Stupak-Wamp Human Cloning Prohibition Act, and H.R. 877, the Forbes-Lipinski Patients First Act. Contacts in support of extension (continued) into new fiscal year of the Dickey-Wicker provision prohibiting the use of funding within the DHHS appropriations bill for "research in which" human embryos are harmed or placed at risk.

Client expense: $122,838 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

Client expense: $10,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office

FY 2012 President's Budget: funding for Ocean Observations and Research Programs H.R. 21, Oceans Conservation, Education and National Strategy for 21st Century Act: funding for ocean and coastal research H.R. 2407, National Climate Service Act of 2009: NOAA (National Oceanic and Atmospheric Administration) climate and ocean research H.R. 2454, American Clean Energy and Security Act of 2009: implementation of National Climate Service Climate Research and Observations, greenhouse gas emission atmospheric verification H.R. 2693, Federal Oil Spill Research Program Act: extramural research, issues regarding the role of research institutions in oil spill recovery and restoration H.R. 2847/S. 3606, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2010: support for basic research and DOE (Department of Energy) Energy Innovation Hubs H.R. 3458, Internet Freedom Preservation Act of 2009: Net neutrality H.R. 4061, Cybersecurity Enhancement Act of 2009: Network preservation H.R. 4808, Stem Cell Research Advancement Act of 2009: issues concerning stem cell research H.R. 5116/S. 3605, America COMPETES Reauthorization Act of 2010: reauthorization provisions for NSF (National Science Foundation), NIST (National Institute of Standards and Technology), and DOE Office of Science; authorization for DOE Energy Innovation Hubs and provisions for STEM (Science, Technology, Engineering and Math) education S. 1252, Oceans and Human Health Reauthorization Act of 2009: development of marine natural products and pharmaceuticals, and implementation mechanisms S. 1373, Federal Research Public Access Act of 2009: open access S. 1538, Black Carbon and Other Aerosols Research Act of 2009: extramural research S. 1539, Greenhouse Gas Observation and Analysis System Act: extramural research S. 1714, Open College Textbook Act of 2009: Net neutrality S. 1733, Clean Energy Jobs and American Power Act: implementation of National Climate Service Climate Research and Observations, greenhouse gas emission atmospheric verification S. 3515, Department of the Interior Research and Technologies for Oil Spill Prevention and Response Act of 2010: extramural research, role of research institutions in oil spill recovery and restoration S. 3605, America Creating Opportunities to Meaningfully Promote Excellence in Technology, Education, and Science (America COMPETES) Reauthorization Act of 2010: entire bill, particularly funding for NIST, ARPA-E (Advanced Research Projects Agency-Energy), NSF, STEM education, and DOE Office of Science S. 3635, Energy and Water Development and Related Agencies Appropriations Act, 2011: Department of Energy nonproliferation and verification research, US Army Corps of Engineers coastal research and monitoring S. 3636, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2011: funding for NSF research, NOAA Geodesy Research and climate and ocean research, and NASA (National Aeronautics and Space Administration) Earth Sciences research, and SWFSC (Southwest Fisheries Science Center) building construction S. 3694, Great Ape Protection Act of 2010: entire bill S. 3766, Stem Cell Research Advancement Act of 2010: issues regarding stem cell research S. 3800, Department of Defense Appropriations Act of 2011: Navy research and ship operations S. 773, Cybersecurity Act of 2009: Network preservation FY 2011 Departments of Commerce, Justice, Science and Related Agencies appropriations bill: funding for the National Science Foundation and the National Textile Center

Client expense: $200,000 · Firm income: Not reported

Government targets: Army, Dept of (Corps of Engineers), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Natl Institute of Standards & Technology (NIST), Natl Institutes of Health (NIH), Natl Oceanic & Atmospheric Administration (NOAA), Natl Science Foundation (NSF), Navy, Dept of, Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, Veterans Affairs, Dept of (VA)

Nominations to the Patient Centered Outcomes Research Institute Board of Governors; allowing federal funds for human embryonic stem cell research: Stem Cell Research Advancement Act (HR 4808/S 3766).

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Vice President of the U.S.

Nominations to the Patient Centered Outcomes Research Institute Board of Governors; allowing federal funds for human embryonic stem cell research: Stem Cell Research Advancement Act (HR 4808/S 3766).

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Vice President of the U.S.

Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Embryonic Stem Cell Research Issues Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Clinical Trials Insurance Coverage Resolution Expressing Support for Designation of September 2010 as Blood Cancer Awareness Month (H.Res. 1433) Comparative Effectiveness Research Proposed Revisions to NIH COI Policy Stem Cell Research Advancement Act (H.R. 4808 / S. 3766) Stem Cell Therapeutic and Research Reauthorization Act of 2010 (S. 3751 / H.R. 6081)

Client expense: $30,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

H.R. 3668/S.3058, Reauthorization of the Special Statutory Funding Program for Type 1 Diabetes Reserach and The Special Diabetes Program for Indians H.R. 4808, Stem Cell Research Advancement Act of 2009 S.3766, Stem Cell Research Advancment Act of 2010

Client expense: $130,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1326, S 3694, Great Ape Protection Act of 2009, All provisions. S 3766, Stem Cell Research Advancement Act of 2010. All provisions.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 5116, HR 5325, S 3605, Reauthorization of America COMPETES Act, Issues pertaining to NSF. S 3694, HR 1326, Great Ape Protection Act, All provisions. S 3766, Stem Cell Research Advancement Act of 2010, All provisions.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 4808 Stem Cell Research Advancement Act expansion of federal funding for human embryonic stem cell research S. 3766 Stem Cell Research Advancement Act - expansion of federal funding for human embryonic stem cell research

Client expense: $120,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1427 To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes HR 1548 To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes. HR5116, S3605 America COMPETES Reauthorization Act of 2010. HR5781, S3729 National Aeronautics and Space Administration Authorization Act of 2010. HR 915 FAA Reauthorization Act of 2009, regarding FAA Centers of Excellence. Issues related to Stem Cell Research including S3766 Stem Cell Research Advancement Act of 2010 and HR 4808 Stem Cell Research Advancement Act of 2009

Client expense: $120,000 · Firm income: Not reported

Government targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE

H.R. 4808/S. 3766, Stem Cell Research Advancement Act. Issue: Support authorization of federal funding for human embryonic stem cell research.

Client expense: $140,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, Veterans Affairs, Dept of (VA), White House Office

S.515, Patent Reform Act of 2009. Patent reform, human embryonic stem cell research. H.R. 4808, S.3766, Stem Cell Research Advancement Act.

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE

S.515, Patent Reform Act of 2009. Patent reform, human embryonic stem cell research. H.R. 4808, S.3766, Stem Cell Research Advancement Act.

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE